Form 6-K DR REDDYS LABORATORIES For: Jul 06
- Wall St climbs as signs of cooling inflation ease rate hike bets
- Futures Rise, Yields and Dollar Decline After July CPI Report
- U.S. consumer price growth unchanged for July
- Twitter Saga Forces Musk to Sell $6.9 Billion of Tesla Shares, Says He's Done Selling
- Coinbase (COIN) Stock Drops on Narrowed User Guidance, Analysts Cut Price Targets
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 1-15182
DR. REDDY’S LABORATORIES LIMITED
(Translation of registrant’s name into English)
8-2-337, Road No. 3, Banjara Hills
Hyderabad, Telangana 500 034, India
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.
|Description of Exhibits|
|99.2||Intimation dated July 6, 2022 titled Notice of 38th Annual General Meeting (AGM) and Annual Report 2021-22|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|DR. REDDY’S LABORATORIES LIMITED|
|Date: July 6, 2022||By:||/s/ K Randhir Singh|
|Name:||K Randhir Singh|
Dr. Reddy’s Laboratories Ltd.
8-2-337, Road No. 3, Banjara Hills,
Hyderabad - 500 034, Telangana,
CIN : L85195TG1984PLC004507
Tel : +91 40 4900 2900
Fax : +91 40 4900 2999
Email : [email protected]
July 6, 2022
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)
BSE Limited (Scrip Code: 500124)
Dear Sir/ Madam,
Sub: Notice of 38th Annual General Meeting (AGM) and Annual Report 2021-22
This is in continuation to our earlier letter dated May 20, 2022, and pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed the Notice convening the 38th AGM of the members of the Company and Annual Report for the financial year 2021-22.
The following documents are available on the Company’s website:
|1)||Notice of 38th Annual General Meeting at https://bit.ly/3bUg59a|
|2)||Annual Report 2021-2022 at https://bit.ly/3P68sut|
The 38th AGM of members of the Company is scheduled to be held on Friday, July 29, 2022, through Video conference/ Other Audio-Visual Means (OAVM).
AGM information at a glance for ready reference:
|Time and date of AGM||9:00 a.m. IST, Friday, July 29, 2022|
|Cut-off date for e-voting||Friday, July 22, 2022|
|E-voting start time and date||9:00 a.m. IST; Monday, July 25, 2022|
|E-voting end time and date||5:00 p.m. IST; Thursday, July 28, 2022|
|E-voting website of NSDL||https://www.evoting.nsdl.com/|
This is for your information and records.
For Dr. Reddy’s Laboratories Limited
|/s/ K Randhir Singh|
|K Randhir Singh|
|Company Secretary & Compliance Officer|
Encl: As above
|CC:||New York Stock Exchange Inc. (Stock Code: RDY)|
NSE IFSC Ltd. (Stock Code: DRREDDY)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Athenex (ATNX) option IV low at 20
- BIC-Acquisition of AMI_10AUG22
- Ace Hardware Opens Over 100 New Stores In 2022 And Continues Distribution Network Expansion
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!